The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation

NCT05220410 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Treatment Resistant Depression
Suicidal Ideation

Interventions

DRUG: Psilocybin

Sponsor

Sheppard Pratt Health System

Collaborators

[object Object]